James Snipes is senior counsel in the firm’s corporate practice and a former chair of the life sciences industry group. For the past twenty years, Mr. Snipes’s practice has focused on corporate and transactional matters for life sciences clients ranging from private, venture-backed biotech companies to multinational pharmaceutical companies. The focus of his practice is strategic collaborations and complex licensing transactions; acquisitions and divestitures; spin-outs; venture investments; and commercial agreements in the biopharmaceutical industry. Mr. Snipes’s international practice experience includes a stint as head of Covington’s corporate group in London and two years at one of Tokyo’s leading corporate law firms.
47
China’s National Development & Reform Commission (“NDRC”) announced this week that it has fined two domestic pharmaceutical companies for monopolizing bulk sales of promethazine hydrochloride in violation of the country’s Anti-Monopoly Law (“AML”). The decision, NDRC’s first AML action in the (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK